Advanced search
Publication Cover
Cell Cycle Volume 21, 2022 - Issue 2
Submit an article Journal homepage
748
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells

Dan Luoa Department of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, Sichuan, ChinaCorrespondence[email protected]
,
Chune Yub Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
,
Jing Yub Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
,
Chao Sub Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
,
Shun Lia Department of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, Sichuan, China
&
Peng Liangc Clover Biopharmaceuticals, Chengdu, Sichuan, ChinaCorrespondence[email protected]
Pages 140-151 | Received 10 May 2021, Accepted 22 Nov 2021, Published online: 08 Dec 2021

References

  • Tokino T, Idogawa M, Sasaki Y. P53 pathway and cancer: from bench to clinic. Pers Med Universe. 2015;4:1–3.
  • Boutelle AM, Attardi LD. p53 and tumor suppression: it takes a network. Trends Cell Biol. 2021;31(4):298–310.
  • Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science. 2013;339(6127):1546–1558.
  • Pflaum J, Schlosser S, Mã¼ller M. p53 family and cellular stress responses in cancer. Front Oncol. 2014;4(4). DOI:https://doi.org/10.3389/fonc.2014.00285
  • Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 1995;55(22):5187–5190.
  • Giono LE, Manfredi JJ. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol. 2006;209(1):13–20.
  • Pitolli C, Wang Y, Candi E, et al. p53-mediated tumor suppression: DNA-damage response and alternative mechanisms. Cancers (Basel). 2019;11(12):1983.
  • Schwab M. P21. 2012.
  • Xiao BD, Zhao Y-J, Jia X-Y, et al. Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy. World J Stem Cells. 2020;12(6):481–487.
  • Zhan J, Easton JB, Huang S, et al. Negative regulation of ASK1 by p21Cip1 involves a small domain that includes serine 98 that is phosphorylated by ASK1 in vivo. Mol Cell Biol. 2007;27(9):3530–3541.
  • Suzuki A, Tsutomi Y, Akahane K, et al. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 1998;17(8):931–939.
  • Starostina NG, Kipreos ET. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol. 2012;22(1):33–41.
  • Li Y, Huang J, Zeng B, et al. PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation. Cancer Lett. 2018;430:109–122.
  • Cho YJ, Liang P. Killin is a p53-regulated nuclear inhibitor of DNA synthesis. Proc Natl Acad Sci U S A. 2008;105(14):5396–5401.
  • Bennett KL, Mester J, Eng C. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA. 2010;304(24):2724–2731.
  • Wang Y, Radhakrishnan D, He X, et al. Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation. J Clin Endocrinol Metab. 2013;98(3):E586–94.
  • Wang Y, He X, Yu Q, et al. Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas. Hum Mol Genet. 2013;22(11):2263–2272.
  • Qiao M, Luo D, Kuang Y, et al. Cell cycle specific distribution of killin: evidence for negative regulation of both DNA and RNA synthesis. Cell Cycle. 2015;14(12):1823–1829.
  • Nizialek EA, Peterson C, Mester JL, et al. Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest. Hum Mol Genet. 2013;22(12):2451–2461.
  • Sankunny M, Eng C. KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cells. Cell Death Discov. 2018;4:92–104.
  • Cho Y-J, Liang P. S-phase-coupled apoptosis in tumor suppression. Cell Mol Life Sci. 2011;68(11):1883–1896.
  • Polyak K, Waldman T, He TC, et al. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 1996;10(15):1945–1952.
  • Gartel AL, Tyner AL. Transcriptional regulation of the p21 (WAF1/CIP1) gene. Exp Cell Res. 1999;246(2):280–289.
  • Zhang L, Hu JJ, Gong F. MG132 inhibition of proteasome blocks apoptosis induced by severe DNA damage. Cell Cycle. 2011;10(20):3515–3518.
  • Dang F, Nie L, Wei W. Ubiquitin signaling in cell cycle control and tumorigenesis. Cell Death Differ. 2020;28(2):427–438.
  • Egunsola AT, Bae Y, Jiang -M-M, et al. Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia. J Clin Invest. 2017;127(4):1475–1484.
  • Nizialek EA, Sankunny M, Niazi F, et al. Cancer-predisposition gene KLLN maintains pericentric H3K9 trimethylation protecting genomic stability. Nucleic Acids Res. 2016;44(8):3586–3594.
  • Sankunny M, Eng C. Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cells. Oncotarget. 2020;11(50):4625–4636.
  • Ma Z, Luo D, Huang A, et al. pKILLIN: a versatile positive-selection cloning vector based on the toxicity of Killin in Escherichia coli. Gene. 2014;544(2):228–235.
  • Wang H, Yang H, Shivalila CS, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 2013;153(4):910–918.
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.